Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations
- 1 December 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (12) , 4154-4161
- https://doi.org/10.1182/blood-2002-03-0936
Abstract
Chronic lymphocytic leukemia (CLL) cells are ineffective antigen-presenting cells (APCs) although CD40-activated CLL cells can stimulate proliferation of autologous and allogeneic T cells. We examined the antigen-presenting capacity of CD40-activated CLL cells as well as dendritic cells pulsed with apoptotic bodies of CLL cells to generate autologous and allogeneic immune responses against CLL cells. Both APC types were capable of generating T-cell lines that proliferate specifically in response to unstimulated CLL cells. Whereas cytotoxic responses against stimulated and unstimulated CLL cells could be repeatedly generated by allogeneic healthy donors, autologous cytotoxic immune responses against CD40-activated and native CLL cells were rarely detected. However, T cells isolated from patients with CLL could recognize and lyse allogeneic stimulated and unstimulated CLL cells, demonstrating that cytotoxic T cells from these tumor-bearing patients are functionally intact.Keywords
This publication has 45 references indexed in Scilit:
- Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell linesOncogene, 2000
- Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cellsBritish Journal of Haematology, 2000
- Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemiaLeukemia, 1999
- Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemiaLeukemia, 1997
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosisClinical and Experimental Immunology, 1990
- The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic miceCell, 1986
- Expression of a transfected human c-myconcogene inhibits differentiation of a mouse erythroleukaemia cell lineNature, 1986
- Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitmentNature, 1986
- Erythroleukemic DifferentiationAnnual Review of Biochemistry, 1978